Laser-induced glaucoma in rabbits.
Argon laser energy was applied to the trabecular meshwork of pigmented rabbits in an attempt to develop an animal model of 'glaucoma'. Laser energy was varied to determine the optimal level needed to produce sustained ocular hypertension. An initial response of ocular hypertension followed by hypotension was observed in all of the animals tested. Approximately half of the laser-treated rabbits developed a secondary buphthalmus and sustained ocular hypertension. In these animals outflow facility was decreased by approximately 60%. Histologic examination at 4- and 8 weeks after laser treatment demonstrated a wound-healing response resulting in closure of the intertrabecular spaces and obstruction of outflow to injected carbon particles. Optic nerve cupping and a loss of ganglion cells were also observed. Topical application of L-timolol (0.5%), pilocarpine (2.0%) and forskolin (1.0%) were found to be effective in decreasing intraocular pressure in the laser-treated, hypertensive eye with no significant effect in control non-laser-treated eyes, suggesting that this model can be a useful tool for screening potential antiglaucoma medications.
D000818:Animals; D001082:Aqueous Humor / Q000502:physiology; D005576:Colforsin / Q000627:therapeutic use; D004195:Disease Models, Animal; D005901:Glaucoma / Q000209:etiology; D007834:Lasers / Q000009:adverse effects*; D009798:Ocular Hypertension / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D009898:Optic Disk / Q000473:pathology; D010862:Pilocarpine / Q000627:therapeutic use; D011817:Rabbits; D013999:Timolol / Q000627:therapeutic use; D014129:Trabecular Meshwork / Q000473:pathology / Q000601:surgery
D010862:Pilocarpine; D005576:Colforsin; D013999:Timolol